Loading
JPXBasic MaterialsChemicals - Specialty
Latest quote
¥1,393
−¥5.50 · -0.39%
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
Latest quote
¥1,393
−¥5.50 · -0.39%
Regular session · JST · Market data may be delayed.
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
Day range
Current ¥1,393
52-week range
Current ¥1,393
Regular session · JST · Market data may be delayed.
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
Day range
Current ¥1,393
52-week range
Current ¥1,393
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 579.63B JPY | 586.53B JPY | 558.06B JPY | 538.03B JPY | 467.94B JPY |
| Cost of goods sold | 433.34B JPY | 420.69B JPY | 397.67B JPY | 390.98B JPY | 328.26B JPY |
| Gross profit | 146.29B JPY | 165.84B JPY | 160.39B JPY | 147.04B JPY | 139.68B JPY |
| Research and development | — | 25.93B JPY | 23.39B JPY | 21.88B JPY | 20.74B JPY |
| Selling, general, and administrative | 104.22B JPY | 78.9B JPY | 74.6B JPY | 77.66B JPY | 68.24B JPY |
| Operating expenses | 104.22B JPY | 104.83B JPY | 97.99B JPY | 99.54B JPY | 88.98B JPY |
| Interest income | 816M JPY | 1.21B JPY | 1.57B JPY | 697M JPY | 236M JPY |
| Interest expense | 3.2B JPY | 1.98B JPY | 1.67B JPY | 1.43B JPY | 1.36B JPY |
| Depreciation and amortization | 43.34B JPY | 41.37B JPY | 33.7B JPY | 31.58B JPY | 28.2B JPY |
| Operating income | 42.07B JPY | 61.01B JPY | 62.39B JPY | 47.51B JPY | 50.7B JPY |
| Net income | 10.18B JPY | 49.48B JPY | 55.84B JPY | 40.68B JPY | 31.25B JPY |
Company facts updated Sep 12, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T762.46M0.03%2.91T JPY0.05%¥413.5-0.48%
iShares JPX-Nikkei 400 ETF1364.T232.71M0.04%595.24B JPY0.05%¥3,707-0.19%
Avantis International Small Cap Value ETFAVDV48.21M0.24%20.51B USD0.36%$111.61+0.72%
Vanguard Total International Stock ETFVXUS31.79M0.00%646.2B USD0.05%$87.14+1.00%
Vanguard FTSE Developed Markets ETFVEA19.74M0.01%315B USD0.03%$72.69+1.07%
iShares Core MSCI EAFE ETFIEFA15.92M0.01%193.07B USD0.07%$99.50+1.00%
Cambria Foreign Shareholder Yield ETFFYLD7.1M0.97%731.19M USD0.59%$41.03+0.74%
iShares MSCI EAFE Small-Cap ETFSCZ6.49M0.05%12.89B USD0.40%$86.09+0.87%iShares Core TOPIX ETF1475.TiShares JPX-Nikkei 400 ETF1364.TAvantis International Small Cap Value ETFAVDVVanguard Total International Stock ETFVXUSVanguard FTSE Developed Markets ETFVEAiShares Core MSCI EAFE ETFIEFACambria Foreign Shareholder Yield ETFFYLDiShares MSCI EAFE Small-Cap ETFSCZAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
